1![article published online: 8 january 2012 | doi: nchembio.765 Oxysterols are allosteric activators of the oncoprotein Smoothened article published online: 8 january 2012 | doi: nchembio.765 Oxysterols are allosteric activators of the oncoprotein Smoothened](https://www.pdfsearch.io/img/2c1ebcfb981b318b71270e627a74b92b.jpg) | Add to Reading ListSource URL: rohatgi.stanford.eduLanguage: English - Date: 2013-02-15 12:38:42
|
---|
2![Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (BCC): 24-month update of the pivotal ERIVANCE BCC study A Sekulic,1 MR Migden,2 AE Oro,3 L Dirix,4 K Lewis,5 JD Hainsworth,6 Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (BCC): 24-month update of the pivotal ERIVANCE BCC study A Sekulic,1 MR Migden,2 AE Oro,3 L Dirix,4 K Lewis,5 JD Hainsworth,6](https://www.pdfsearch.io/img/14dfae88f6a91c12d3f9967680c78f42.jpg) | Add to Reading ListSource URL: www.curis.comLanguage: English - Date: 2014-05-12 19:51:02
|
---|
3![Vismodegib, a Hedgehog Pathway Inhibitor, in Advanced Basal Cell Carcinoma: STEVIE Study Interim Analysis in 300 Patients Jean-Jacques Grob, Rainer Kunstfeld, Brigitte Dréno, Thomas Jouary, Laurent Mortier, Paolo A. Asc Vismodegib, a Hedgehog Pathway Inhibitor, in Advanced Basal Cell Carcinoma: STEVIE Study Interim Analysis in 300 Patients Jean-Jacques Grob, Rainer Kunstfeld, Brigitte Dréno, Thomas Jouary, Laurent Mortier, Paolo A. Asc](https://www.pdfsearch.io/img/4d15db14055b6c10de0b320727fe5f9a.jpg) | Add to Reading ListSource URL: www.curis.comLanguage: English - Date: 2014-05-12 19:51:02
|
---|
4![8579 Efficacy and Safety of the Hedgehog Pathway Inhibitor Vismodegib in Patients With Advanced Basal Cell Carcinoma (BCC): ERIVANCE BCC Study Update Aleksandar Sekulic,1 Michael R Migden,2 Anthony E Oro,3 Karl Lewis,4 8579 Efficacy and Safety of the Hedgehog Pathway Inhibitor Vismodegib in Patients With Advanced Basal Cell Carcinoma (BCC): ERIVANCE BCC Study Update Aleksandar Sekulic,1 Michael R Migden,2 Anthony E Oro,3 Karl Lewis,4](https://www.pdfsearch.io/img/da4e61a57704af1023fe35a50f0dec97.jpg) | Add to Reading ListSource URL: www.curis.comLanguage: English - Date: 2014-05-12 19:51:02
|
---|
5![Long-Term Safety and Efficacy of Vismodegib in Patients With Advanced Basal Cell Carcinoma (aBCC): 18-Month Update of the Pivotal ERIVANCE BCC Study Aleksandar Sekulic,1 Michael R. Migden,2 Nicole Basset-Seguin,3 Claus G Long-Term Safety and Efficacy of Vismodegib in Patients With Advanced Basal Cell Carcinoma (aBCC): 18-Month Update of the Pivotal ERIVANCE BCC Study Aleksandar Sekulic,1 Michael R. Migden,2 Nicole Basset-Seguin,3 Claus G](https://www.pdfsearch.io/img/9b06016da8c22291e76658ffcf882ff8.jpg) | Add to Reading ListSource URL: www.curis.comLanguage: English - Date: 2014-05-12 19:51:30
|
---|
6![Skin tumors develop specific mutations to resist drug, researchers say Skin tumors develop specific mutations to resist drug, researchers say](https://www.pdfsearch.io/img/4f4233fcc0eba0a48a82b97a63c654ee.jpg) | Add to Reading ListSource URL: medicalxpress.comLanguage: English - Date: 2015-04-13 14:02:44
|
---|
7![NATIONAL CANCER DRUG FUND PRIORITISATION SCORES Drug Indication VISMODEGIB NATIONAL CANCER DRUG FUND PRIORITISATION SCORES Drug Indication VISMODEGIB](https://www.pdfsearch.io/img/ccd319f743f988742e6fdc32891601b3.jpg) | Add to Reading ListSource URL: www.england.nhs.ukLanguage: English - Date: 2013-10-02 10:04:37
|
---|
8![Roche Infographic - Advanced Basal Cell Carcinoma (BCC) Roche Infographic - Advanced Basal Cell Carcinoma (BCC)](https://www.pdfsearch.io/img/df7487ec8357e928cead723f1f53704a.jpg) | Add to Reading ListSource URL: www.roche.comLanguage: English - Date: 2013-07-12 04:22:31
|
---|
9![Microsoft Word - Advanced Basal Cell Carcinoma Microsoft Word - Advanced Basal Cell Carcinoma](https://www.pdfsearch.io/img/d47c2b1a82b4cefb586a69d9112dbfc0.jpg) | Add to Reading ListSource URL: www.roche.comLanguage: English - Date: 2013-07-08 10:50:29
|
---|
10![Vismodegib Briefing Package: Pediatric ODAC Subcommittee Meeting (1 November 2011) Vismodegib Briefing Package: Pediatric ODAC Subcommittee Meeting (1 November 2011)](https://www.pdfsearch.io/img/d1db624fb3b70ba89b5cb6b908bb2cc3.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|